(CHRS) Coherus Biosciences complete technical analysis [charts+indicators] | Buy/Sell Coherus Biosciences | (CHRS) share price targets
Complete technical analysis of Coherus Biosciences (CHRS) by charts plus indicators, forecast predictions and share price targets for Coherus Biosciences (CHRS)
Coherus Biosciences trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-09 View latest technical analysis
10 day averaged volume of Coherus Biosciences is 1059730
| Date | Daily Closing Price | Open | High | Low | Volume |
| 09 Mon Sep 2024 | 1.31 | 1.26 | 1.32 | 1.23 | 1.013 times |
| 06 Fri Sep 2024 | 1.24 | 1.32 | 1.35 | 1.22 | 1.62 times |
| 05 Thu Sep 2024 | 1.32 | 1.32 | 1.35 | 1.29 | 0.643 times |
| 04 Wed Sep 2024 | 1.31 | 1.35 | 1.39 | 1.30 | 1.06 times |
| 03 Tue Sep 2024 | 1.36 | 1.34 | 1.42 | 1.30 | 1.194 times |
| 30 Fri Aug 2024 | 1.39 | 1.43 | 1.44 | 1.37 | 0.56 times |
| 30 Fri Aug 2024 | 1.39 | 1.43 | 1.44 | 1.37 | 0.56 times |
| 29 Thu Aug 2024 | 1.42 | 1.38 | 1.49 | 1.36 | 1.38 times |
| 28 Wed Aug 2024 | 1.36 | 1.37 | 1.41 | 1.34 | 0.849 times |
| 27 Tue Aug 2024 | 1.39 | 1.45 | 1.46 | 1.38 | 0.656 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 1.3 as stoploss in an intra day buy trade for a target of 1.35. However, stock will show a bearish move below 1.3.
Share price targets for Coherus Biosciences (CHRS)
| Target Type | Value |
| Downside Target | 1.21 |
| Upside Target | 1.32 |
| Upside Target | 1.37 |
| Upside Target | 1.42 |
| Upside Target | 1.44 |
| Upside Target | 1.49 |
| Upside Target | 1.55 |
| Upside Target | 1.57 |
| Upside Target | 1.81 |
| Upside Target | 1.87 |
| Upside Target | 1.91 |
| Upside Target | 2.32 |
Intraday share price targets for Coherus Biosciences (CHRS)
| Target Type | Value |
| Downside Intraday Target | 1.25 |
| Downside Intraday Target | 1.2 |
| Upside Intraday Target | 1.34 |
| Upside Intraday Target | 1.38 |
| Downside Intraday Target | 1.29 |
Weekly technical analysis of Coherus Biosciences (CHRS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 09 Mon Sep 2024 | 1.31 | 1.26 | 1.32 | 1.23 | 0.224 times |
| 06 Fri Sep 2024 | 1.24 | 1.34 | 1.42 | 1.22 | 8.063 times |
| 30 Fri Aug 2024 | 1.39 | 1.43 | 1.44 | 1.37 | 0.114 times |
| 30 Fri Aug 2024 | 1.39 | 1.41 | 1.49 | 1.34 | 0.581 times |
| 23 Fri Aug 2024 | 1.39 | 1.29 | 1.43 | 1.21 | 0.682 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Coherus Biosciences (CHRS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 09 Mon Sep 2024 | 1.31 | 1.34 | 1.42 | 1.22 | 0.143 times |
| 30 Fri Aug 2024 | 1.39 | 1.54 | 1.57 | 1.21 | 1.067 times |
| 31 Wed Jul 2024 | 1.54 | 1.73 | 1.91 | 1.25 | 1.25 times |
| 28 Fri Jun 2024 | 1.73 | 1.84 | 1.87 | 1.55 | 0.847 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Coherus Biosciences (CHRS)
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Coherus Biosciences stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Coherus Biosciences in short term but the buy signal is initial and weak.
Coherus Biosciences Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Coherus Biosciences in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Coherus Biosciences is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.34 and Coherus Biosciences (CHRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Coherus Biosciences (CHRS) stock. Volume based technical analysis of Coherus Biosciences (CHRS) stock is negative.
Coherus Biosciences Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Coherus Biosciences stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Coherus Biosciences in short term but the buy signal is initial and weak.
Coherus Biosciences Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Coherus Biosciences in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Coherus Biosciences is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.34 and Coherus Biosciences (CHRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Coherus Biosciences (CHRS) stock. Volume based technical analysis of Coherus Biosciences (CHRS) stock is negative.
Coherus Biosciences Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.